Pembrolizumab,Lenvatinib,Regorafenib,trifluridine,Tipiracil
Merck,Eisai,Bayer,Taiho pharma,Pfizer
['pembro']
 when the wave of pembro/len trials entered the portfolio, expectations were high. it is disappointing that only a couple (rcc, endometrial) affected practice meaningfully.
Medical Oncologist. Focus on #BreastCancer. Lifelong learner 📖 Travel ✈️ Hike 🥾 Cook 🥘 Workout 🏋️‍♀️ Video games 🎮 Tweets are my own opinions.